Format

Send to

Choose Destination
Nat Rev Clin Oncol. 2011 Dec 20;9(2):76-8. doi: 10.1038/nrclinonc.2011.198.

Bone cancer in 2011: Prevention and treatment of bone metastases.

Author information

1
Sheffield Cancer Research Center, Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK. r.e.coleman@sheffield.ac.uk

Abstract

Bone-targeting treatments have transformed the quality of life of patients with metastatic bone disease. 2011 saw the emergence of denosumab—a RANK ligand-specific antibody—as a more-effective alternative treatment to bisphosphonates and of data on the use of bone-targeting treatments to prevent metastasis from breast and prostate cancers.

PMID:
22182971
DOI:
10.1038/nrclinonc.2011.198
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center